- Home
- VERA vs FIHL Comparison
VERA vs FIHL Comparison
Compare VERA & FIHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- FIHL
- Stock Information
- Founded
- VERA 2016
- FIHL 2014
- Country
- VERA United States
- FIHL Bermuda
- Employees
- VERA N/A
- FIHL N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- FIHL
- Sector
- VERA Health Care
- FIHL
- Exchange
- VERA Nasdaq
- FIHL Nasdaq
- Market Cap
- VERA 2.5B
- FIHL 2.1B
- IPO Year
- VERA 2021
- FIHL 2023
- Fundamental
- Price
- VERA $42.01
- FIHL $17.43
- Analyst Decision
- VERA Strong Buy
- FIHL Buy
- Analyst Count
- VERA 9
- FIHL 9
- Target Price
- VERA $53.56
- FIHL $20.50
- AVG Volume (30 Days)
- VERA 683.6K
- FIHL 302.1K
- Earning Date
- VERA 11-07-2024
- FIHL 11-12-2024
- Dividend Yield
- VERA N/A
- FIHL 2.30%
- EPS Growth
- VERA N/A
- FIHL N/A
- EPS
- VERA N/A
- FIHL 3.82
- Revenue
- VERA N/A
- FIHL $2,151,300,000.00
- Revenue This Year
- VERA N/A
- FIHL N/A
- Revenue Next Year
- VERA N/A
- FIHL $13.62
- P/E Ratio
- VERA N/A
- FIHL $4.55
- Revenue Growth
- VERA N/A
- FIHL N/A
- 52 Week Low
- VERA $9.68
- FIHL $11.55
- 52 Week High
- VERA $50.78
- FIHL $20.53
- Technical
- Relative Strength Index (RSI)
- VERA 52.57
- FIHL 46.22
- Support Level
- VERA $39.22
- FIHL $17.24
- Resistance Level
- VERA $50.00
- FIHL $17.74
- Average True Range (ATR)
- VERA 2.41
- FIHL 0.34
- MACD
- VERA 0.24
- FIHL -0.04
- Stochastic Oscillator
- VERA 28.53
- FIHL 28.79
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About FIHL Fidelis Insurance Holdings Limited
Fidelis Insurance Holdings Ltd is a global (re)insurance company. It classify the business into three underwriting segments, namely Bespoke, Specialty and Reinsurance. Specialty primarily comprises property D&F, energy, marine and aviation lines. Bespoke primarily comprises credit and political risk and other tailored solutions for clients including transactional liabilities and credit insurance. Reinsurance primarily comprises property reinsurance.